Analysis reveals glutamine depletion alters metabolism in breast and pancreatic cancer cells, suggesting new therapies.
Motivation: Glutamine plays essential roles in tumor growth and response to treatment. Goal(s): To understand the impact of Gln depletion on cancer metabolism, we characterized metabolic alterations in pancreatic and breast cancer cells under Gln deprivation . Approach: We used 1H MRS to understand the metabolic reprogramming caused by glutamine depletion in two pancreatic and two breast cancer cell lines. Results: The changes in metabolism were accompanied by a significant reduction of cancer cell viability. Glutathione and succinate commonly decreased. We also observed, a significant increase of total choline, glycerophosphocholine and choline that may represent an adaptive metabolic response of cancer cells to glutamine depletion. Impact: Targeting glutamine metabolism may offer a promising therapeutic approach, as acute glutamine depletion induces significant metabolic reprogramming in PDAC and breast cancer cells.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: